$GTCH GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is researching an external device for arterial and tissue imaging based on its proprietary radio technology, combined with the company’s robotic research. The research contemplates an external unit targeted to be operated with a robotic arm to scan designated bodily areas and provide an image of arteries and tissues. The main advantage of the contemplated system is its pure non-invasive nature.
The research is part of the Hermes capsule research project. The Hermes capsule research targets an intravenous mini-probe unit that travels within the artery, searching to find arterial clogs. Hermes unit is based on radio waves-based imaging to produce a computerized 3D imaging for the operating physician. The unit is contemplated to be AI empowered, non-surgical, minimally invasive, safe method for autonomous and/or manual blood vessels blockage detection and cleaning. The research is focused on developing a complementary unit, which is an external probe is targeted to provide more imaging information for arterial and tissue imaging.
The research is examining an external probe that will scan the designated body area that can be mounted on an AI controlled robotic arm, and use radio wave technology to provide 3D imaging of arteries/tissues on a computer screen for a physician review. The research is also evaluating a manually used external probe, as a hand-held unit, similar to typical ultrasound units. The main purpose of the external unit would be to enable external tissue and arterial AI based imaging with great depth and resolution. The external unit will be a combined work of GBT’s medical robotic and Hermes capsule imaging research.